Moleculin Biotech: Of This Current Report On Form 8k, Including Exhibit 99.1, Is Being Furnished And Shall Not Be Filed For The Purpose Of The Securities Exchange Act Of 1934, As Amended ( Exchange Act ), Nor Shall It Be Incorporated By Reference In Any Filing Under The Exchange Act Or The Securities Act Of 1933, As Amended ( Securities Act ), Unless Specifically Identified Therein As Being Incorporated By Reference

Show full article

This functionality is available for registred users only

• Full name
  Moleculin Biotech, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***